Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS

HIV Med. 2007 Jul;8(5):300-5. doi: 10.1111/j.1468-1293.2007.00474.x.

Abstract

Objective: The aim of the study was to assess the prevalence of and factors associated with use of complementary or alternative medicine (CAM) in a multistate, multisite cohort of HIV-infected patients.

Methods: During 2003, 951 adult patients from 14 sites participated in face-to-face interviews. Patients were asked if they received treatment from any alternative therapist or practitioner in the previous 6 months. Logistic regression was performed to examine associations between demographic and clinical variables and CAM use.

Results: The majority of the participants were male (68%) and African American (52%) with a median age of 45 years (range 20-85 years). Sixteen per cent used any CAM in the 6 months prior to the interview. Factors associated with use of CAM were the HIV risk factor injecting drug use [adjusted odds ratio (AOR) 0.51] compared with men who have sex with men (MSM), former drug use (AOR=2.12) compared with never having used drugs, having a college education (AOR=2.43), and visiting a mental health provider (AOR=2.76).

Conclusions: This study demonstrated similar rates of CAM use in the current highly active antiretroviral therapy (HAART) era compared with the pre-HAART era. Factors associated with CAM - such as education, use of mental health services, and MSM risk factor - suggest that CAM use may be associated with heightened awareness regarding the availability of such therapies. Given the potential detrimental interactions of certain types of CAM and HAART, all HIV-infected patients should be screened for use of CAM.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Complementary Therapies / psychology
  • Complementary Therapies / statistics & numerical data*
  • Female
  • HIV / growth & development*
  • HIV Infections / drug therapy
  • HIV Infections / psychology
  • HIV Infections / therapy*
  • HIV Infections / virology
  • Humans
  • Interviews as Topic
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • RNA, Viral / blood
  • Socioeconomic Factors
  • United States

Substances

  • RNA, Viral